Pill Identifier Xeljanz XR - NDC 63539-501
Tofacitinib
Product Code 63539-501
Xeljanz XR by U.s. Pharmaceuticals is a pink oval tablet extended release about 8 mm in size, imprinted with jki11. The product is a human prescription drug with active ingredient(s) tofacitinib.
Xeljanz XR
Active Ingredient(s): Tofacitinib
Inactive Ingredient(s):
- SORBITOL
- HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)
- COPOVIDONE K25-31
- MAGNESIUM STEARATE
- CELLULOSE ACETATE
- HYDROXYPROPYL CELLULOSE (1600000 WAMW)
- TITANIUM DIOXIDE
- HYPROMELLOSE 2910 (6 MPA.S)
- TRIACETIN
- FERRIC OXIDE RED
- SHELLAC
- AMMONIA
- PROPYLENE GLYCOL
- FERROSOFERRIC OXIDE
U.s. Pharmaceuticals
Product Type: Human Prescription Drug
Dosage Form: Tablet, Extended Release
- Pink (C48328)
Product Packages
NDC Package Code | Package Description |
---|---|
63539-501-14 | 14 TABLET, EXTENDED RELEASE in 1 BOTTLE |
63539-501-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE |
* Please review the disclaimer below.
Pill Identification data last updated on: December, 2018
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product. If this is an emergency, call 911 or the national Poison Help hotline at 1-800-222-1222. Most images are not part of the product labels and have not been verified by the labeler company. ALWAYS consult your physician or pharmacist with any medication-related questions.